sapraa.org.za - /presentations/Sept2009/


[To Parent Directory]

9/14/2009 2:41 PM 831488 20090824SAPRAA.ppt
9/8/2009 8:50 AM 64799 Bioanalytical Method Validation FDA 2001.pdf
9/8/2009 8:51 AM 755274 Biowaver Application Form (BCS).pdf
9/8/2009 8:51 AM 70405 Botswana Checklist for Variations 2009.pdf
9/8/2009 8:51 AM 227116 Botswana Guidelines for Stability Studies 2009.pdf
9/8/2009 8:51 AM 192579 Botswana Guidelines on Bioavailability and Bioequivalence 2009.pdf
9/8/2009 8:51 AM 265164 Botswana Guidelines on Good Manufacturing Practices 2009.pdf
9/8/2009 8:51 AM 25584 Botswana Variations Application Form 2009.pdf
9/8/2009 8:51 AM 235008 Changes to MRA-MCC Sept09-Dr. Gouws.ppt
9/8/2009 8:50 AM 283304 Clinical trial Guidelines.pdf
9/8/2009 8:52 AM 3141120 CPD - SAPRAA. Lorraine.Osmond.ppt
9/8/2009 8:53 AM 1192186 Dossier Requirements for Variations 2009.pdf
9/8/2009 8:53 AM 36352 DRAFT GUIDELINES DISCUSSED AT DRU WORKSHOP 17-19 June 09.doc
9/8/2009 8:53 AM 789504 DRU STAKEHOLDERS' WORKSHOP-Liz Filby.ppt
9/8/2009 8:53 AM 386845 Guidelines on Drug Registration Applications in Botswana 2009.pdf
9/8/2009 8:51 AM 193816 Impuriries of new drug product ICH 2006.pdf
9/8/2009 8:54 AM 195142 Impurities of new substances ICH 2006.pdf
9/8/2009 8:54 AM 159446 Pharmaceutical Development ICH 2009.pdf
9/8/2009 8:54 AM 138410 Qualification and Validation EMEA 2001.pdf
9/8/2009 8:55 AM 5364224 SAPRAA 4Sept'09.Prof Barry Schoub.ppt
9/8/2009 8:53 AM 184192 Validation of analytical method ICH 1994.pdf